Study of the safety and efficacy of donafenib combined with toripalimab in patients with non-MSI-H metastatic colorectal cancer

ABSTRACT: Interventions: experimental group:Donafenib + Toripalimab Primary outcome(s): Objective response rate Study Design: Single arm

DISEASE(S): Colorectal Cancer

PROVIDER: 2717190 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR